German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology, University of Cologne,Aachen Bonn Cologne Duesseldorf, K鈧琽ln, Germany, Department of Haematology, Christian Medical College, Vellore, India, Division of Hematology, Department of Medicine, Faculty of Medicin...
In 4.4% of human immunodeficiency virus-associated non-Hodgkin's lymphoma the presenting lesion is seen in the mouth. Often the lesion may clinically resem... F Silvia,DM Luigino,LV Carlo - 《International Journal of Cancer》 被引量: 252发表: 1999年 Non-Hodgkin's lymphoma of mucosa-associat...
Although similar, Hodgkin's and Non-Hodgkin lymphoma have different approaches to treatment. Here is what newly diagnosed patients should know.
'How I treat advanced Hodgkin lymphoma – a global view'. Br J Haematol. 2020;190:837–50 M Picardi,C Giordano,RD Pepa,... - 《British Journal of Haematology》 被引量: 0发表: 2021年 Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and ...
This is an important test that I recommend getting every time you check your thyroid function. TSH is a pituitary hormone that responds to low/high amounts of circulating thyroid hormone. If you’re new to thyroid lab testing, it may seem counterintuitive, but an elevated TSH means that you...
Forty-four children aged 3-13 years with Murphy stage III B cell non-Hodgkin's lymphoma were treated between May 1986 and December 1989. All have been followed up for at least 12 months. The primary site was the abdomen in 37 children, 24 of whom had involvement of other organs or noda...
Thank you. I have been diagnosed with Hodgkin’s lymphoma and believe in our Lord Jesus Christ. After having 1 round of chemo, I knew there has to be a better way. My body is the temple of the Holy Spirit and I will treat it as such. Your story gives me hope and that I can fu...
David Maloney, MD, PhD, medical director, Cellular Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center, discusses the results of the ZUMA trial and how chimeric antigen receptor CAR T-cell therapy is changing the treatment landscape for non-Hodgkin lymphoma....
Curcumin has been found to have clinical therapeutic and prevention potential for cancer patients in in vitro and in vivo animal and human clinical studies for colorectal, liver, pancreatic, lung, breast, uterine, ovarian, prostate, bladder, kidney, renal, brain, non-Hodgkin lymphoma and leukemia...
PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemmaPET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma:...